Technology curve awarded U.S. Patent on Nasal Drug Delivery Technologycurve Technology, a leading developer of nasal drug delivery devices, a U.S. Patent was covering his ViaNase electronic nebulizer line output. ‘The granting of this patent confirms our technology leadership, reflects our innovation and protects our intellectual property,’said Marc Giroux, CEO of the technology curve. ‘This is just another step in curve mission to redefine the possibilities of the new nasal drug delivery. ‘.
The result is a flexible intranasal technology platform that can deliver virtually any liquid drug without reformulation. The conveyor regardless of viscosity or surface tension CPD enables pharmaceutical companies deliver topical, systemic, and nose – to-brain drugs and vaccines with minimal peripheral deposition in the lungs and stomach.. Controlled Particle DispersionThe ViaNase equipment line includes Controlled Particle dispersions technology six critical six critical-to – function design parameters, modification of the deposit and The result features. Continue reading “Technology curve awarded U.”